Source: Annual Congress 2006 - Epidemiology of susceptible, resistant and multidrug-resistant tuberculosis (MDR-TB)
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. P. Tonkel, G. G. Peremitin, O. B. Sirotkina, A. K. Strelis, A. D. Pasechnikov, A. B. Yedilbayev, A. A. Golubkov, Y. G. Andreev (Tomsk, Russian Federation; Boston, United States Of America). Analysis of treatment failure in cohort I of the Tomsk DOTS-plus program (2000–2002). Eur Respir J 2006; 28: Suppl. 50, 2247

Member's Comments

No comment yet.

Related content which might interest you: Cohort analysis of a large community-based latent tuberculosis screening and treatment programme in a high incidence setting in East London Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Pilot project for DOTS implementation in sector IV, Bucharest, Romania: first 12 month analysis Source: Eur Respir J 2001; 18: Suppl. 33, 174s Year: 2001 MDR TB treatment results of GFATM program implementation in Tomsk, Russia Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Strengthening the DOTS-Plus TB Control Programme in Estonia 2002-2004 (a pilot project for intensified case finding in high-risk groups in the Ida-Virumaa region) Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005 Effectiveness of mandatory treatment for tuberculosis - An observational registry study Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013 Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia) Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Results of DOTS strategy within the tuberculosis control program in Bucharest, Romania Source: Eur Respir J 2005; 26: Suppl. 49, 648s Year: 2005 Tuberculosis treatment outcome monitoring in European Union countries: systematic review Source: Eur Respir J 2013; 41: 635-643 Year: 2013 Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Psychiatric disorders in MDR TB patients on the treatment regimens under DOTS-plus programme in Tomsk oblast penitentiary system Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001 Aspects of effective MDR-TB treatment in the prison hospital, Tomsk (Russia) Source: Eur Respir J 2006; 28: Suppl. 50, 17s Year: 2006 Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Programmatic management of drug resistance tuberculosis: Outcome analysis of 200 patients in western part of Rajasthan, India Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Therapeutic failure among incident users of ß-lactam antibiotics: a real-world, cohort study, in primary care in Italy Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 Particularities of a cohort of preXDR / XDR TB patients treated with group 5 medication, hospitalized in MDR TB Department Institute of Pneumophtisiology Bucharest, Romania Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Screening coverage and treatment loss to follow-up of Diabetes and Tuberculosis (TB) patients in hospitals with measures to integrate care of Diabetes and TB and those without integration measures in Malawi Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Improved treatment outcome of MDR-TB in Eastern Taiwan: Reducing default rate by DOTS Plus Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013 2 years and a half experience in pilot project for DOTS implementation, Sector IV Bucharest (Romania) Source: Eur Respir J 2003; 22: Suppl. 45, 521s Year: 2003 Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015